Ethionamide
Formulations: - Oral > Solid > dispersible tablet: 125 mg Oral > Solid > tablet: 250 mg Indications: - Tuberculous meningitis - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Price on request
New Arrivals
Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
New Arrivals (Showing 468 out of 662)
Imipenem + Cilastatin
Formulations: - Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection Indications: - Peritonitis (severe) - Peritoneal abscess (severe) - Neutropenia (high-risk) Source: EML workbook import
MOQ: 1
Price on request
Isoniazid
Formulations: - Parenteral > General injections > IV: 100 mg per mL Oral > Solid > dispersible tablet: 100 mg (scored) Oral > Solid > tablet: 100 mg; 300 mg Indications: - Other specified tuberculosis - Tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Isoniazid + Pyrazinamide + Rifampicin
Formulations: - Oral > Solid > dispersible tablet: 50 mg + 150 mg + 75 mg Indications: - Tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Isoniazid + Rifampicin
Formulations: - Oral > Solid > dispersible tablet: 50 mg + 75 mg Oral > Solid > tablet: 75 mg + 150 mg; 150 mg + 300 mg Indications: - Tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Isoniazid + Rifapentine
Formulations: - Oral > Solid: 300 mg + 300 mg tablet (scored) Indications: - Latent tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Levofloxacin
Formulations: - Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 250 mg; 500 mg; 750 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Linezolid
Formulations: - Oral > Solid > dispersible tablet: 150 mg (scored) Oral > Solid > tablet: 600 mg - Parenteral > General injections > IV: 2 mg per mL in 300 mL bag Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 400 mg tablet; 600 mg tablet Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 600 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis - Other specified bacterial diseases - Methicillin resistant Staphylococcus aureus - Vancomycin resistant Staphylococcus aureus - Vancomycin resistant Enterococcus Source: EML workbook import
MOQ: 1
Price on request
Meropenem
Formulations: - Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection Indications: - Multi-drug resistant Mycobacterium tuberculosis - Neonatal meningitis - Peritonitis (severe) - Peritoneal abscess (severe) - Neutropenia (high-risk) Source: EML workbook import
MOQ: 1
Price on request
Moxifloxacin
Formulations: - Oral > Solid > tablet: 400 mg Oral > Solid > dispersible tablet: 100 mg Indications: - Tuberculosis - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Price on request
P-Aminosalicylate Sodium
Formulations: - Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Pretomanid
Formulations: - Oral > Solid > tablet: 200 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.